Literature DB >> 16801473

The aspirin resistance controversy: clinical entity or platelet heterogeneity?

Jane E Freedman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16801473     DOI: 10.1161/CIRCULATIONAHA.106.635847

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  An inconvenient truth: recognizing individual differences in arteriogenesis.

Authors:  Jalees Rehman
Journal:  Circ Res       Date:  2008-05-23       Impact factor: 17.367

2.  Aspirin resistance: Fact or fiction? A point of view.

Authors:  Jawahar L Mehta; Bhavna Mohandas
Journal:  World J Cardiol       Date:  2010-09-26

Review 3.  Aspirin resistance in atherosclerosis.

Authors:  Price Blair; Jane E Freedman
Journal:  Curr Atheroscler Rep       Date:  2008-04       Impact factor: 5.113

4.  A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability.

Authors:  J Enrique Herrera-Galeano; Diane M Becker; Alexander F Wilson; Lisa R Yanek; Paul Bray; Dhananjay Vaidya; Nauder Faraday; Lewis C Becker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-29       Impact factor: 8.311

5.  Aspirin treatment failure: is this a real phenomenon? A review of the aetiology and how to treat it.

Authors:  F Shahid; C A A Chahal; M J Akhtar
Journal:  JRSM Short Rep       Date:  2013-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.